Vice President of Business Development
TransPharma, Inc.
They’re focusing on developing products that are delivered with unique transdermal delivery. It’s the company’s lead product.
The transdermal delivery system’s ease of use points:
-Convenient handling by the patient
-Room temperature storage
-Ready for use
-Easy administration
-Portable
-Picket size product
-No device maintenance
Two patches: printed patches and matrix patches
Current products: ViaDerm hPTH1, ViaDerm-GLP1 (in pipeline)
There are currently 4 clinical trials in the pipeline:
-Positive experience with patients
-Strong clinical data
-scaled up manufacturing lines
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment